Difference between revisions of "Editorial Board"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "#3182bd" to "#08519c") |
Warner-admin (talk | contribs) m |
||
Line 84: | Line 84: | ||
|- | |- | ||
|rowspan=3 style="background-color:#F0F0F0"|[[File:Michaelgibson.jpg|frameless|upright=0.4|center]] | |rowspan=3 style="background-color:#F0F0F0"|[[File:Michaelgibson.jpg|frameless|upright=0.4|center]] | ||
− | |rowspan=3|<big>[[User:Michaelgibson|Michael Gibson, MD, PhD]]<br>Nashville, TN</big> | + | |rowspan=3|<big>[[User:Michaelgibson|Michael Gibson, MD, PhD]]<br>Nashville, TN</big><br>Twitter: [https://twitter.com/mgibson21212 mgibson21212]<br>[https://www.linkedin.com/in/michael-gibson-65137032/ LinkedIn] |
|style="background-color:#deebf7"|[[Head and neck cancer]] | |style="background-color:#deebf7"|[[Head and neck cancer]] | ||
|- | |- |
Revision as of 04:06, 16 January 2018
We have recently appointed an editorial board of clinical experts, organized primarily by disease focus. Many disease sites now have expert representation, but we are still looking for potential section or page editors. If you are interested, please feel free to contact us with any questions or inquiries, at [email protected].
Editor-in-Chief
Peter C. Yang, MD Boston, MA Twitter: Hem_Onc |
Deputy Editor
Jeremy L. Warner, MD, MS Nashville, TN Twitter: Hemoncwarner |